Chronic low-level expression of HIV-1 Tat promotes a neurodegenerative phenotype with aging

Alex M. Dickens, Seung Wan Yoo, Alfred C. Chin, Jiadi Xu, Tory Johnson, Amanda L. Trout, Kurt F. Hauser, Norman Haughey

Research output: Contribution to journalArticle

Abstract

The widespread use of combinational antiretroviral therapies (cART) in developed countries has changed the course of Human Immunodeficiency Virus (HIV) infection from an almost universally fatal disease to a chronic infection for the majority of individuals. Although cART has reduced the severity of neurological damage in HIV-infected individuals, the likelihood of cognitive impairment increases with age, and duration of infection. As cART does not suppress the expression of HIV non-structural proteins, it has been proposed that a constitutive production of HIV regulatory proteins in infected brain cells may contribute to neurological damage. However, this assumption has never been experimentally tested. Here we take advantage of the leaky tetracycline promoter system in the Tat-transgenic mouse to show that a chronic very low-level expression of Tat is associated with astrocyte activation, inflammatory cytokine expression, ceramide accumulation, reductions in brain volume, synaptic, and axonal damage that occurs over a time frame of 1 year. These data suggest that a chronic low-level production of Tat may contribute to progressive neurological damage in virally suppressed HIV-infected individuals.

Original languageEnglish (US)
Article number7748
JournalScientific Reports
Volume7
Issue number1
DOIs
StatePublished - Dec 1 2017

Fingerprint

HIV-1
HIV
Phenotype
Human Immunodeficiency Virus Proteins
Viral Structural Proteins
Ceramides
Brain
Virus Diseases
Infection
Tetracycline
Developed Countries
Astrocytes
Transgenic Mice
Therapeutics
Cytokines

ASJC Scopus subject areas

  • General

Cite this

Chronic low-level expression of HIV-1 Tat promotes a neurodegenerative phenotype with aging. / Dickens, Alex M.; Yoo, Seung Wan; Chin, Alfred C.; Xu, Jiadi; Johnson, Tory; Trout, Amanda L.; Hauser, Kurt F.; Haughey, Norman.

In: Scientific Reports, Vol. 7, No. 1, 7748, 01.12.2017.

Research output: Contribution to journalArticle

Dickens, Alex M. ; Yoo, Seung Wan ; Chin, Alfred C. ; Xu, Jiadi ; Johnson, Tory ; Trout, Amanda L. ; Hauser, Kurt F. ; Haughey, Norman. / Chronic low-level expression of HIV-1 Tat promotes a neurodegenerative phenotype with aging. In: Scientific Reports. 2017 ; Vol. 7, No. 1.
@article{b4d357abe9d9430180c9368238b927cc,
title = "Chronic low-level expression of HIV-1 Tat promotes a neurodegenerative phenotype with aging",
abstract = "The widespread use of combinational antiretroviral therapies (cART) in developed countries has changed the course of Human Immunodeficiency Virus (HIV) infection from an almost universally fatal disease to a chronic infection for the majority of individuals. Although cART has reduced the severity of neurological damage in HIV-infected individuals, the likelihood of cognitive impairment increases with age, and duration of infection. As cART does not suppress the expression of HIV non-structural proteins, it has been proposed that a constitutive production of HIV regulatory proteins in infected brain cells may contribute to neurological damage. However, this assumption has never been experimentally tested. Here we take advantage of the leaky tetracycline promoter system in the Tat-transgenic mouse to show that a chronic very low-level expression of Tat is associated with astrocyte activation, inflammatory cytokine expression, ceramide accumulation, reductions in brain volume, synaptic, and axonal damage that occurs over a time frame of 1 year. These data suggest that a chronic low-level production of Tat may contribute to progressive neurological damage in virally suppressed HIV-infected individuals.",
author = "Dickens, {Alex M.} and Yoo, {Seung Wan} and Chin, {Alfred C.} and Jiadi Xu and Tory Johnson and Trout, {Amanda L.} and Hauser, {Kurt F.} and Norman Haughey",
year = "2017",
month = "12",
day = "1",
doi = "10.1038/s41598-017-07570-5",
language = "English (US)",
volume = "7",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Chronic low-level expression of HIV-1 Tat promotes a neurodegenerative phenotype with aging

AU - Dickens, Alex M.

AU - Yoo, Seung Wan

AU - Chin, Alfred C.

AU - Xu, Jiadi

AU - Johnson, Tory

AU - Trout, Amanda L.

AU - Hauser, Kurt F.

AU - Haughey, Norman

PY - 2017/12/1

Y1 - 2017/12/1

N2 - The widespread use of combinational antiretroviral therapies (cART) in developed countries has changed the course of Human Immunodeficiency Virus (HIV) infection from an almost universally fatal disease to a chronic infection for the majority of individuals. Although cART has reduced the severity of neurological damage in HIV-infected individuals, the likelihood of cognitive impairment increases with age, and duration of infection. As cART does not suppress the expression of HIV non-structural proteins, it has been proposed that a constitutive production of HIV regulatory proteins in infected brain cells may contribute to neurological damage. However, this assumption has never been experimentally tested. Here we take advantage of the leaky tetracycline promoter system in the Tat-transgenic mouse to show that a chronic very low-level expression of Tat is associated with astrocyte activation, inflammatory cytokine expression, ceramide accumulation, reductions in brain volume, synaptic, and axonal damage that occurs over a time frame of 1 year. These data suggest that a chronic low-level production of Tat may contribute to progressive neurological damage in virally suppressed HIV-infected individuals.

AB - The widespread use of combinational antiretroviral therapies (cART) in developed countries has changed the course of Human Immunodeficiency Virus (HIV) infection from an almost universally fatal disease to a chronic infection for the majority of individuals. Although cART has reduced the severity of neurological damage in HIV-infected individuals, the likelihood of cognitive impairment increases with age, and duration of infection. As cART does not suppress the expression of HIV non-structural proteins, it has been proposed that a constitutive production of HIV regulatory proteins in infected brain cells may contribute to neurological damage. However, this assumption has never been experimentally tested. Here we take advantage of the leaky tetracycline promoter system in the Tat-transgenic mouse to show that a chronic very low-level expression of Tat is associated with astrocyte activation, inflammatory cytokine expression, ceramide accumulation, reductions in brain volume, synaptic, and axonal damage that occurs over a time frame of 1 year. These data suggest that a chronic low-level production of Tat may contribute to progressive neurological damage in virally suppressed HIV-infected individuals.

UR - http://www.scopus.com/inward/record.url?scp=85045956908&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045956908&partnerID=8YFLogxK

U2 - 10.1038/s41598-017-07570-5

DO - 10.1038/s41598-017-07570-5

M3 - Article

C2 - 28798382

AN - SCOPUS:85045956908

VL - 7

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 7748

ER -